This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYVE, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,147.45 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00. The IDC, which is part of the DLA's ECAT Generation V Program, allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of November 12, 2024.
Generated 2/7/25, 9:21 AM